Sep 22, 2020

Huntsman Cancer Institute Joins Nationwide Effort to Address COVID-19’s Impact on Cancer Prevention and Treatment

A group of 17 cancer centers around the country have banded together in a major new initiative to better understand how the COVID-19 pandemic is affecting cancer care and prevention.

Sep 18, 2020

Committed to a Positive and Lasting Impact: The Engelstad Foundation

Samuel Cheshier, MD, PhD, and the Neurologic Cancers Center team at Huntsman Cancer Institute are working to find better treatments for brain cancer, particularly pediatric brain cancer. Many primary brain tumors are incurable from the start, and currently, none are curable once they recur. The need for novel, effective therapies is critical. In 2020, the Engelstad Foundation funded a $100,000 grant at HCI to study a potential immunotherapy treatment for pediatric brain tumors.

Sep 16, 2020

To Reduce Colorectal Cancer Disparities among African American Men, More Intervention Research Is Urgently Needed

Out of any other racial group, African American men have the lowest five-year survival rate for colorectal cancer. Published research on effective strategies to increase screening for this group specifically are minimal. These findings were published today in a special health inequities and disparities issue of the journal PLOS ONE.

Sep 10, 2020

Novel Discovery Challenges a Current Kidney Cancer Paradigm

Newly published research has reversed our understanding of an aspect of kidney tumor growth. Researchers at Huntsman Cancer Institute at the University of Utah discovered that two key proteins have opposite roles than what was previously believed.

Aug 21, 2020

Huntsman Cancer Institute Researchers Receive Grants from St. Baldrick’s Foundation Amid Pandemic

Two researchers at Huntsman Cancer Institute at the University of Utah received awards from the St. Baldrick’s Foundation to fund innovative childhood cancer research.

Aug 04, 2020

Scientists Develop New Models to Accelerate Progress in Preventing Drug Resistance in Lung and Pancreas Cancers

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.

Jul 31, 2020

Huntsman Cancer Institute Research Illuminates Potential New Treatment Approach in Acute Myeloid Leukemia

In a study published in the journal Leukemia, lead author Ami Patel, MD, showed that factors produced by bone marrow support cells allowed leukemia cells to survive treatment with quizartinib, a type of TKI.

Jul 21, 2020

Huntsman Cancer Institute Receives Renewal of Prestigious Designation from the National Cancer Institute

The National Cancer Institute has renewed the designation of Huntsman Cancer Institute (HCI) at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization. This grant awards HCI more than $29 million over seven years, an increase of 84% in annual funding from the previous award cycle.